Table 3. HSCT outcome parameters in TM patients.
| S. No | Parameter | N (%) |
|---|---|---|
| 1 | Engraftment | |
| Yes | 82 (97.6%) | |
| No | 02 (2.4%) | |
| NE | 03 | |
| 2 | Day28 chimerism | |
| Complete | 77 (92.5%) | |
| Mixed | 06 (7.5%) | |
| NE | 07 | |
| 3 | Rejection | |
| Yes | 05 (6.2%) | |
| No | 75 (93.8%) | |
| NE | 07 | |
| 4 | Mucositis | |
| Grade 1-2 | 17 (19.5%) | |
| Grade 3-4 | 17 (19.5%) | |
| Nil | 53 (61%) | |
| 5 | Pulmonary SOS | |
| Yes | 07 (8%) | |
| No | 80 (92%) | |
| 6 | Hepatic SOS | |
| Yes | 16 (18.4%) | |
| No | 71 (81.6%) | |
| 7 | OS status | |
| Alive | 68 (78.2%) | |
| Dead | 19 (21.8%) | |
| 8 | EFS status | |
| Event | 21 (24.1%) | |
| No event | 66 (75.9%) | |
| 9 | D+100 TRM | |
| Yes | 15 (17.2%) | |
| No | 72 (82.8%) |
NE, not evaluable; NA, not available; SOS, sinusoidal obstruction syndrome; aGVHD, acute graft versus host disease; cGVHD, chronic graft versus host disease; OS, overall survival; EFS, event-free survival; D+100 TRM, day 100 transplant related mortality.